Endoscope + Radiofrequency Ablation (RFA) Market Size to Reach $7,471 Million by 2025

Pune, Maharashtra, India, February 26 2021 (Wiredrelease) Allied Analytics –:Endoscopic RFA is an advanced treatment modality, which is commonly applied in the treatment of medical indication such as uncoordinated heartbeats, Barrett’s esophagus, and pain management, and others. Radiofrequency ablation is considered to be an FDA-approved advanced endoscopic technique in which the diseased tissue is exposed to heat energy for its destruction or removal. The global endoscope + radiofrequency ablation (RFA) market was valued at $3,567.4 million in 2017 and is estimated to reach at $7,471.5 million by 2025, registering a CAGR of 9.6% from 2018 to 2025.

Upsurge in geriatric population that is highly susceptible to pain and chronic disorders has a positive impact on the market growth. In addition, rise in need for the development of advanced minimally invasive surgical techniques has propelled the demand for endoscopic RFA across healthcare settings, thus fueling the market growth.

Download Sample PDF Of Report@ https://www.alliedmarketresearch.com/request-sample/4705

However, dearth of skilled professionals that lack complete know-how of endoscopic RFA treatment impedes the market growth. Conversely, high untapped potential in the emerging economies is anticipated to offer significant profitable opportunities for the expansion of the market.

The endoscope + radiofrequency ablation (RFA) market is segmented based on application. On the basis of application, the market is categorized into cardiology applications, pain management, oncology applications, and others.

On the basis of application, the market is classified into cardiology application, pain management, oncology application, and other application. Among these, the cardiology application segment accounted for the largest share of the revenue generated in 2017 and is anticipated to maintain this trend throughout the forecast period. However, the oncology application segment is expected to grow at the fastest pace from 2018 to 2025.

Key Findings of the Endoscope + Radiofrequency Ablation (RFA) Market :

-The pain management segment accounted for approximately 29% of the global market share in 2017.

– Europe accounted for more than 30.0% share of the global endoscope + RFA market in 2017 and is expected to maintain this trend throughout the forecast period.

– India is anticipated to grow at the fastest pace in the Asia-Pacific market, registering a CAGR of 12.8% from 2018 to 2025.

– U.S. has generated the highest revenue in 2017 in the North America market and is expected to maintain this dominance throughout the forecast period.

North America was the leading revenue contributor to the global market in 2017 and is expected to maintain this dominance throughout the forecast period. This is attributed to the fact that North America is an established market for radiofrequency device ablation technologies, wherein countries in this region adopt novel RFA devices including endoscope + RFA devices at the earliest. However, Asia-Pacific is expected to grow at the highest CAGR from 2018 to 2025, because this region is home to the worlds most diverse population groups and encompasses both developing and underdeveloped economies. With increase in burden of diseases across these countries, Asia-Pacific is anticipated to offer profitable opportunities for the market players focusing on expansion.

For Purchase Enquiry:  https://www.alliedmarketresearch.com/purchase-enquiry/4705

The major companies profiled in this report include Boston Scientific Corporation Conmed Corporation, Medtronic Plc (Covidien Plc), Smith & Nephew Plc, Stryker Corporation, Halyard Health, Inc., Abbott Laboratories (St. Jude Medical, Inc.), AngioDynamics, Inc., Hologic, Inc., and AtriCure, Inc. Other prominent players in the value chain include Diros Technology, Inc., Arthrex, Inc., Biotronik, Cosman Medical, Inc., Fcare Systems, Johnson & Johnson (Biosense Webster & DePuy Mitek), Stockert GmbH, and ENDO-FLEX GmbH.

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This content has been published by Allied Analytics company. The WiredRelease News Department was not involved in the creation of this content. For press release service enquiry, please reach us at contact@wiredrelease.com.